These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 3553271)

  • 1. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit.
    Westaby S
    Intensive Care Med; 1987; 13(2):89-95. PubMed ID: 3553271
    [No Abstract]   [Full Text] [Related]  

  • 2. Mini extracorporeal circuit cardiopulmonary bypass system: a review.
    Curtis N; Vohra HA; Ohri SK
    Perfusion; 2010 May; 25(3):115-24. PubMed ID: 20581025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Response and Endothelial Dysfunction Following Cardiopulmonary Bypass: Pathophysiology and Pharmacological Targets.
    Giacinto O; Satriano U; Nenna A; Spadaccio C; Lusini M; Mastroianni C; Nappi F; Chello M
    Recent Pat Inflamm Allergy Drug Discov; 2019; 13(2):158-173. PubMed ID: 31339081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary complications of cardiopulmonary bypass.
    Huffmyer JL; Groves DS
    Best Pract Res Clin Anaesthesiol; 2015 Jun; 29(2):163-75. PubMed ID: 26060028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inflammatory response to miniaturised extracorporeal circulation: a review of the literature.
    Vohra HA; Whistance R; Modi A; Ohri SK
    Mediators Inflamm; 2009; 2009():707042. PubMed ID: 20101278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The systemic inflammatory response to cardiopulmonary bypass and the brain.
    Smith PL
    Perfusion; 1996 May; 11(3):196-9. PubMed ID: 8817627
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune consequences, pathophysiology, and current perspectives of the extracorporeal circulation.
    Wildhirt SM; Tárnok A
    Shock; 2001; 16 Suppl 1():1-2. PubMed ID: 11770025
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic inflammatory responses to surgery with cardiopulmonary bypass.
    Royston D
    Perfusion; 1996 May; 11(3):177-89. PubMed ID: 8817625
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic inflammatory response and the splanchnic bed in cardiopulmonary bypass.
    Ohri SK
    Perfusion; 1996 May; 11(3):200-12. PubMed ID: 8817628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory response to cardiopulmonary bypass.
    Butler J; Rocker GM; Westaby S
    Ann Thorac Surg; 1993 Feb; 55(2):552-9. PubMed ID: 8431082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of interleukin 10 in inflammatory response after cardiovascular surgery with cardiopulmonary bypass].
    Paśnik J
    Postepy Hig Med Dosw (Online); 2006; 60():8-14. PubMed ID: 16407789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Two Miniaturized Cardiopulmonary Bypass Systems Regarding Inflammatory Response.
    Farag M; Patil NP; Sabashnikov A; Arif R; Szabó G; Kallenbach K; Ruhparwar A; Karck M; Brenner T; Hofer S; Weymann A
    Artif Organs; 2017 Feb; 41(2):139-145. PubMed ID: 27653813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The history of the concept of inflammatory responses to cardiopulmonary bypass.
    Utley JR
    Perfusion; 1996 May; 11(3):190-5. PubMed ID: 8817626
    [No Abstract]   [Full Text] [Related]  

  • 15. Extracorporeal circulation, hemocompatibility, and biomaterials.
    Janvier G; Baquey C; Roth C; Benillan N; Bélisle S; Hardy JF
    Ann Thorac Surg; 1996 Dec; 62(6):1926-34. PubMed ID: 8957436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troubleshooting the rat model of cardiopulmonary bypass: effects of avoiding blood transfusion on long-term survival, inflammation and organ damage.
    Samarska IV; Henning RH; Buikema H; Bouma HR; Houwertjes MC; Mungroop H; Struys MM; Absalom AR; Epema AH
    J Pharmacol Toxicol Methods; 2013; 67(2):82-90. PubMed ID: 23328058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of biomaterials on inflammatory responses to cardiopulmonary bypass.
    Courtney JM; Matata BM; Yin HQ; Esposito A; Mahiout A; Taggart DP; Lowe GD
    Perfusion; 1996 May; 11(3):220-8. PubMed ID: 8817630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The early inflammatory response in a mini-cardiopulmonary bypass system: a prospective randomized study.
    Kiaii B; Fox S; Swinamer SA; Rayman R; Higgins J; Cleland A; Fernandes P; MacDonald J; Dobkowski WB; Stitt LW; Novick RJ; Singh B; Bureau Y; Summers K
    Innovations (Phila); 2012; 7(1):23-32. PubMed ID: 22576032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil Phenotype Correlates With Postoperative Inflammatory Outcomes in Infants Undergoing Cardiopulmonary Bypass.
    Huber JN; Hilkin BM; Hook JS; Brophy PD; Davenport TL; Davis JE; Colaizy TT; Moreland JG
    Pediatr Crit Care Med; 2017 Dec; 18(12):1145-1152. PubMed ID: 29068910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drew-Anderson technique attenuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting.
    Richter JA; Meisner H; Tassani P; Barankay A; Dietrich W; Braun SL
    Ann Thorac Surg; 2000 Jan; 69(1):77-83. PubMed ID: 10654491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.